Departamento de Química, Universidade Federal de Santa Maria, 97105-900 Santa Maria, RS, Brazil.
Departamento de Química, Universidade Federal de Santa Maria, 97105-900 Santa Maria, RS, Brazil.
J Pharm Biomed Anal. 2024 Jan 20;238:115802. doi: 10.1016/j.jpba.2023.115802. Epub 2023 Oct 16.
Microwave-assisted wet digestion (MAWD) using only HO was proposed for oxidizing active pharmaceutical ingredients (APIs) for hypertension treatment and subsequent determination by inductively coupled plasma optical emission spectrometry (ICP-OES). Diltiazem hydrochloride (DIL) presented the most refractory characteristic for oxidation using MAWD-HO. This proposed MAWD-HO method was validated for specificity, accuracy, and precision according to United States Pharmacopeia (USP) Chapter 233 guidelines. Regarding specificity, the most sensitive emission lines were utilized to analyze all elemental impurities in the digests, and no significant spectral interferences were observed. Sample masses of 500 mg for all APIs and a digestion temperature of 250 °C provided digests with residual carbon (RC) below 2400 mg L of C. Additionally, the residual acidity of the MAWD-HO digests was lower than the acidity presented by the HNO digests. The highest and lowest residual carbon content (RCC) for digests were observed for DIL and captopril (CAP), respectively, using MAWD-HO. When comparing the RCC for MAWD-HO and MAWD-HNO digests for APIs containing aromatic rings, it was evident that HO offered equivalent conditions for digesting these compounds. Accuracy tests showed recovery values of 91-110% for all elemental impurities, as recommended by USP chapter 233. Validation experiments for precision presented relative standard deviation (RSD) values below 6.4% and 10% under repeatability and intermediate precision conditions, respectively. The limits of quantification (LOQs) provided by MAWD-HO are at most half of those recommended by of USP and International Council for Harmonisation of Technical Requirements (ICH). In conclusion, MAWD-HO can be considered an alternative method for API digestion, aligning with green analytical chemistry principles, as it does not employ toxic reagents, minimizes waste, and the main products of HO oxidation are water and oxygen. Considering the analytical Eco-Scale, the MAWD-HO method scored 81, classifying it as an excellent green analysis.
微波辅助湿消解(MAWD)仅使用 HO 被提议用于氧化治疗高血压的活性药物成分(APIs),并随后通过电感耦合等离子体光学发射光谱法(ICP-OES)进行测定。盐酸地尔硫卓(DIL)在使用 MAWD-HO 氧化时表现出最具抗性的特征。根据美国药典(USP)第 233 章指南,该提议的 MAWD-HO 方法经过了特异性、准确性和精密度的验证。关于特异性,使用最灵敏的发射线分析消化物中的所有元素杂质,并且没有观察到明显的光谱干扰。对于所有 API,样品质量为 500mg,消解温度为 250°C,可使残留碳(RC)低于 2400mg·L-1·C。此外,MAWD-HO 消化物的残留酸度低于 HNO 消化物的酸度。MAWD-HO 消化物的最高和最低残留碳含量(RCC)分别观察到 DIL 和卡托普利(CAP)。当比较含芳环的 API 的 MAWD-HO 和 MAWD-HNO 消化物的 RCC 时,HO 为消化这些化合物提供等效条件是显而易见的。准确性测试显示,所有元素杂质的回收率为 91-110%,符合 USP 第 233 章的建议。精密度验证实验的相对标准偏差(RSD)值分别在重复性和中间精密度条件下低于 6.4%和 10%。MAWD-HO 提供的定量限(LOQ)最多是 USP 和国际人用药品注册技术协调会(ICH)建议的一半。总之,MAWD-HO 可以被认为是 API 消化的替代方法,符合绿色分析化学原则,因为它不使用有毒试剂,最大限度地减少废物,并且 HO 氧化的主要产物是水和氧气。考虑到分析生态规模,MAWD-HO 方法得分为 81,将其归类为优秀的绿色分析。